Article Sidebar

PDF
Date Published: 24/02/2023
Abstract Views: 112
Views PDF: 98
DOI: https://doi.org/10.51298/vmj.v523i1.4455
Issue
Vol. 523 No. 1 (2023)
Section
Các bài báo
How to Cite
Lê, H. T. ., Lê, V. T. ., Đỗ, T. D. ., Ngô, V. T. ., & Lê, T. H. (2023). PREVALENCE OF SARS-COV-2 INFECTION IN PATIENTS EXAMINED AND TREATED AT GENERAL HOSPITAL NINH THUAN 2022. Vietnam Medical Journal, 523(1). https://doi.org/10.51298/vmj.v523i1.4455

PREVALENCE OF SARS-COV-2 INFECTION IN PATIENTS EXAMINED AND TREATED AT GENERAL HOSPITAL NINH THUAN 2022

Huy Thạch Lê1,, Văn Thanh Lê1, Thùy Dung Đỗ1, Văn Thắng Ngô1, Thị Hoa Lê1
1 Ninh Thuan general hospital

Main Article Content

Abstract

Introduction: SARS-CoV-2 infection was first reported in 2019, and has since spread throughout the world. Objective: Determine prevalence of SARS-CoV-2 infection and concentrations of some paraclinical tests in infected patients. Methods: Descriptive   cross-sectional   study   on   600 patients examined and treated at general hospital Ninh Thuan from January to September 2022. Results: 33/600 patients were confirmed to be infected with SARS-CoV-2 (5.5%), male 4.8% and female 5.8%, median age of infected patients is 36 years. Most infections were mild (75.8%), the median WBC count in patients infected with SARS-CoV-2 was 4.600/mm3, lymphocytes 1.100/mm3, platelets 180.000/mm3, hemoglobin 12.2 g/dl, CRP > 10 mg% accounted for 9.1%, ferritin 200 ng/mL, there were difference in the median white blood cell count; lymphocytes; ferritin between the 2 groups mild and moderate with severe (p<0.05). The cut-off point to determine the moderate and severe disease in patients infected with SARS-CoV-2 of lymphocytes ≥ 900/mm3 (AUC=0.8, p<0.01, sensitivity 92%, specificity 88%) and ferritin ≥ 266 ng/ml (AUC=0.9, p<0.001, sensitivity 88%, specificity 92%). Conclusion: Approximately 5.5% of patients infected with SARS-CoV-2 come to examination and treatment at hospital. Lymphocytes and ferritin are valuable in determining moderate and severe disease in patients with SARS-CoV-2 infection.

Article Details

Keywords

COVID-19, General hospital Ninh thuan

References

1. Boehmer T. K, et al (2020), “Changing age distribution of the COVID-19 pandemic-United States, May–August 2020”, Morbidity and Mortality Weekly Report,, 69(39), 1404.
2. Chen G, Wu D. I, Guo W, et al (2020), “Clinical and immunological features of severe and moderate coronavirus disease 2019”, The Journal of clinical investigation, 130(5), 2620-2629.
3. Guan W. J, Ni Z. Y, Hu Y, et al (2020), “Clinical characteristics of coronavirus disease 2019 in China”, New England journal of medicine, 382(18), 1708-1720.
4. Jacob L, Koyanagi A, Smith L, et al (2021), “Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021”, International Journal of Infectious Diseases, 111, 37-42.
5. Liu T, Zhang J, Yang Y, et al (2020), “The potential role of IL-6 in monitoring severe case of coronavirus disease 2019”, MedRxiv.
6. de Lusignan S, Dorward J, Correa A, et al (2020), “Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study”, The Lancet Infectious Diseases, 20(9), 1034-1042.
7. Mani N. S, Budak J. Z., Lan K. F, et al (2020), “Prevalence of coronavirus disease 2019 infection and outcomes among symptomatic healthcare workers in Seattle, Washington”, Clinical Infectious Diseases, 71(10), 2702-2707.
8. Setiadi W, Rozi I. E, Safari D, et al (2022), “Prevalence and epidemiological characteristics of COVID-19 after one year of pandemic in Jakarta and neighbouring areas, Indonesia: A single center study”, PloS one, 17(5), e0268241.
9. Wang D, et al (2020), “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan”, China. Jama, 323(11), 1061-1069.